Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Are the Pancreatic Serum Proteins Pancreatic Stone Protein (PSP) and Pancreatitis-Associated Protein (PAP) Predictive for the Development of Sepsis? Retrospective Study in Trauma Patients With Soft Tissue Defects.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007 by University of Zurich.
Recruitment status was  Recruiting
Information provided by:
University of Zurich Identifier:
First received: November 26, 2007
Last updated: March 17, 2008
Last verified: November 2007

Retrospective analysis of PSP- and PAP-serum levels in trauma patients with soft tissue defects and possible correlation with the incidence and onset of infection and sepsis.

Condition Intervention
Trauma Patients With Soft Tissue Defects
Procedure: retrospective Observation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by University of Zurich:

Estimated Enrollment: 15
Study Start Date: August 2005
Estimated Study Completion Date: January 2008
Intervention Details:
    Procedure: retrospective Observation
    retrospective Observation

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Trauma patients


Inclusion criteria:

  • Trauma patients submitted to the university hospital Zurich, aged 18-65 with soft tissue defects

Exclusion criteria:

  • Patients with known immunocompromising illnesses, drug abuse or infectious diseases.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00564109

Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: Marius Keel, University Hospital Zurich Identifier: NCT00564109     History of Changes
Other Study ID Numbers: StV 10-2003
Study First Received: November 26, 2007
Last Updated: March 17, 2008
Health Authority: Switzerland: Swissmedic processed this record on February 27, 2015